NRx Pharmaceuticals (NRXP) Competitors $2.80 -0.08 (-2.78%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$2.90 +0.10 (+3.57%) As of 04:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NRXP vs. CRGX, RAPT, TIL, TRDA, SLS, HRTX, IMRX, GNFT, TLSA, and EPRXShould you be buying NRx Pharmaceuticals stock or one of its competitors? The main competitors of NRx Pharmaceuticals include CARGO Therapeutics (CRGX), Rapt Therapeutics (RAPT), Instil Bio (TIL), Entrada Therapeutics (TRDA), SELLAS Life Sciences Group (SLS), Heron Therapeutics (HRTX), Immuneering (IMRX), GENFIT (GNFT), Tiziana Life Sciences (TLSA), and Eupraxia Pharmaceuticals (EPRX). These companies are all part of the "pharmaceutical products" industry. NRx Pharmaceuticals vs. Its Competitors CARGO Therapeutics Rapt Therapeutics Instil Bio Entrada Therapeutics SELLAS Life Sciences Group Heron Therapeutics Immuneering GENFIT Tiziana Life Sciences Eupraxia Pharmaceuticals NRx Pharmaceuticals (NASDAQ:NRXP) and CARGO Therapeutics (NASDAQ:CRGX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment and earnings. Do analysts recommend NRXP or CRGX? NRx Pharmaceuticals currently has a consensus price target of $34.50, indicating a potential upside of 1,132.14%. CARGO Therapeutics has a consensus price target of $15.40, indicating a potential upside of 244.52%. Given NRx Pharmaceuticals' stronger consensus rating and higher possible upside, equities research analysts clearly believe NRx Pharmaceuticals is more favorable than CARGO Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NRx Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.00CARGO Therapeutics 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86 Which has better valuation & earnings, NRXP or CRGX? NRx Pharmaceuticals is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNRx PharmaceuticalsN/AN/A-$25.13M-$2.24-1.25CARGO TherapeuticsN/AN/A-$167.50M-$4.64-0.96 Is NRXP or CRGX more profitable? NRx Pharmaceuticals' return on equity of 0.00% beat CARGO Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets NRx PharmaceuticalsN/A N/A -550.94% CARGO Therapeutics N/A -43.21%-37.26% Which has more volatility & risk, NRXP or CRGX? NRx Pharmaceuticals has a beta of 1.63, indicating that its share price is 63% more volatile than the S&P 500. Comparatively, CARGO Therapeutics has a beta of 0.3, indicating that its share price is 70% less volatile than the S&P 500. Do institutionals & insiders have more ownership in NRXP or CRGX? 4.3% of NRx Pharmaceuticals shares are owned by institutional investors. Comparatively, 93.2% of CARGO Therapeutics shares are owned by institutional investors. 19.0% of NRx Pharmaceuticals shares are owned by company insiders. Comparatively, 2.9% of CARGO Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media favor NRXP or CRGX? In the previous week, NRx Pharmaceuticals had 27 more articles in the media than CARGO Therapeutics. MarketBeat recorded 28 mentions for NRx Pharmaceuticals and 1 mentions for CARGO Therapeutics. NRx Pharmaceuticals' average media sentiment score of 1.02 beat CARGO Therapeutics' score of 0.00 indicating that NRx Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NRx Pharmaceuticals 5 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CARGO Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryNRx Pharmaceuticals beats CARGO Therapeutics on 11 of the 14 factors compared between the two stocks. Get NRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NRXP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NRXP vs. The Competition Export to ExcelMetricNRx PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$55.47M$2.54B$5.78B$10.18BDividend YieldN/A57.24%5.73%4.60%P/E Ratio-1.2523.6475.5726.02Price / SalesN/A545.33461.9291.11Price / CashN/A27.5625.8129.91Price / Book-1.895.3812.526.25Net Income-$25.13M$32.95M$3.29B$270.76M7 Day Performance-1.41%1.21%0.78%2.54%1 Month Performance-3.11%5.08%4.56%5.73%1 Year Performance62.79%-1.67%66.82%25.85% NRx Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NRXPNRx Pharmaceuticals3.1508 of 5 stars$2.80-2.8%$34.50+1,132.1%+62.8%$55.47MN/A-1.252Positive NewsCRGXCARGO Therapeutics1.6606 of 5 stars$4.47flat$15.40+244.5%N/A$216.17MN/A-0.96116News CoverageRAPTRapt Therapeutics4.2343 of 5 stars$13.28+2.7%$21.57+62.4%+4.0%$213.83M$1.53M-0.9480News CoverageAnalyst UpgradeTILInstil Bio2.8188 of 5 stars$25.77-18.2%$119.00+361.8%-71.5%$212.65MN/A-1.99410Insider TradeHigh Trading VolumeTRDAEntrada Therapeutics2.5231 of 5 stars$5.28-0.2%$25.67+386.1%-64.8%$201.22M$210.78M-2.97110SLSSELLAS Life Sciences Group1.3553 of 5 stars$1.90-0.5%$7.00+268.4%+40.2%$201.12M$1M-5.9410HRTXHeron Therapeutics4.1484 of 5 stars$1.30-0.8%$4.50+246.2%-32.6%$200.81M$144.29M-65.00300Positive NewsIMRXImmuneering3.4332 of 5 stars$5.95+8.0%$13.00+118.5%+320.3%$200.12M$320K-3.1560GNFTGENFIT1.9108 of 5 stars$3.96+0.5%$9.00+127.3%+2.5%$197.01M$76.77M0.00120Upcoming EarningsTLSATiziana Life Sciences0.5554 of 5 stars$1.62-2.4%N/A+82.7%$193.97MN/A0.008Short Interest ↑EPRXEupraxia Pharmaceuticals2.4804 of 5 stars$5.27-2.2%$11.00+108.7%+106.6%$193.82MN/A-6.2029Positive News Related Companies and Tools Related Companies CARGO Therapeutics Alternatives Rapt Therapeutics Alternatives Instil Bio Alternatives Entrada Therapeutics Alternatives SELLAS Life Sciences Group Alternatives Heron Therapeutics Alternatives Immuneering Alternatives GENFIT Alternatives Tiziana Life Sciences Alternatives Eupraxia Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NRXP) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NRXP Stock Alerts